SCHEMBL8970290

SCHEMBL8970290

O=C1[C@H]2CCCC[C@H]2C(=O)N1Cc1ccncc1

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.70
PDE4A P27815 1/20 0.48
PDE4B Q07343 1/20 0.48
PDE4C Q08493 1/20 0.48
PDE4D Q08499 1/20 0.48
MT-CO2 P00403 1/20 0.47
ALOX5 P09917 1/20 0.47
LMNA P02545 4/20 0.45
KDM4E B2RXH2 2/20 0.45
RAB9A P51151 2/20 0.45
TDP1 Q9NUW8 1/20 0.45
SMN1; SMN2 Q16637 3/20 0.44
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
HTT P42858 1/20 0.41
CA12 O43570 1/20 0.41
CA1 P00915 1/20 0.41
CA2 P00918 1/20 0.41
CA9 Q16790 1/20 0.41
KCNH2 Q12809 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8970292 1.00 ALDH1A1 (0.70) ALDH1A1PDE4APDE4BPDE4CPDE4D
SCHEMBL8383162 0.82 ALDH1A1 (1.00) ALDH1A1MT-CO2ALOX5LMNASMN1; SMN2
SCHEMBL8383160 0.82 ALDH1A1 (1.00) ALDH1A1MT-CO2ALOX5LMNASMN1; SMN2
SCHEMBL7829113 0.79 ALDH1A1 (0.93) ALDH1A1MT-CO2ALOX5LMNASMN1; SMN2
SCHEMBL3716740 0.79 ALDH1A1 (0.93) ALDH1A1MT-CO2ALOX5LMNASMN1; SMN2
SCHEMBL17532457 0.77 ALDH1A1 (0.77) ALDH1A1PDE4APDE4BPDE4CPDE4D
SCHEMBL45048 0.76 ALDH1A1 (0.64) ALDH1A1PDE4APDE4BPDE4CPDE4D
SCHEMBL45049 0.76 ALDH1A1 (0.64) ALDH1A1PDE4APDE4BPDE4CPDE4D
SCHEMBL5455762 0.74 CYP1B1 (0.44) ALDH1A1LMNAKDM4EMEN1KMT2A
SCHEMBL11265344 0.73 USP2 (0.54) ALDH1A1MT-CO2ALOX5LMNARAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5480892-A SIGMA RECEPTOR ANTAGONISTS; TREATMENT OF PHYSIOLOGICAL OR DRUG INDUCED PSYCHOSIS AND DYSKINESIA THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1996-01-02 US disclosed
US-5356906-A (N-phthalimidoalkyl) piperidines useful as treatments for psychosis THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1994-10-18 US disclosed
WO-1993022310-A1 (N-PHTHALIMIDOALKYL)PIPERIDINES FOR THE TREATMENT OF PSYCHOSES THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1993-11-11 WO disclosed
WO-1991006297-A1 (N-PHTHALIMIDOALKYL) PIPERIDINES THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1991-05-16 WO disclosed